So, Binimetinib is this MEK inhibitor thing. It’s mainly used to treat melanoma with this BRAF V600E/K mutation, and it works best when it’s paired up with encorafenib. It works by blocking something called MEK signaling.
You get it in these 15 mg tablets. They suggest taking 45 mg two times a day. Each bottle has 84 tablets in it.
The therapeutic use is specifically for melanoma patients who have the BRAF V600E/K mutation, and it is important to note that this drug is intended to be used under the supervision of a healthcare professional. They’ve worked out the dosage from studies that showed how well it works and how safe it is for melanoma patients with that BRAF thing. Binimetinib is just one of those targeted therapies.
It tries to mess with this MEK enzyme, which is kind of a big deal in cancer growth, especially if you have that mutation.
Reviews
There are no reviews yet.